Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. - Wikidata - wikimedia - TriplyDB

Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

http://www.wikidata.org/entity/Q34000829

about

Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers Recent Developments in Peptide-Based Nucleic Acid Delivery Progress toward therapy with antisense-mediated splicing modulation Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice Molecular Biology and Infection of Hepatitis E Virus Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy A 20-amino acid module of protein kinase C{epsilon} involved in translocation and selective targeting at cell-cell contacts Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice.Gene knockdowns in adult animals: PPMOs and vivo-morpholinos.The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus.Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum.Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.Basic peptide-morpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes.Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.Combined effect of a peptide-morpholino oligonucleotide conjugate and a cell-penetrating peptide as an antibiotic.Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle.Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies.Inhibition of norovirus replication by morpholino oligomers targeting the 5'-end of the genome.Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice.Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.Targeting RNA to treat neuromuscular disease.Cell-penetrating peptides for the delivery of nucleic acids.Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.Sequence-defined shuttles for targeted nucleic acid and protein delivery.Sequence-defined polymers for the delivery of oligonucleotides.Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.Cell-Penetrating Peptides for Antiviral Drug Development.Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides

P2860

Q24298547-D00AB9F5-2572-4A1A-BA9F-22F6E9C1B5C8 Q24682873-3C4D2798-7A95-453F-8302-9A0B63D8F090 Q27481059-2680FBFD-840D-4192-BAF9-F20A5A4DE47D Q27486045-33D59267-E9AC-4DDC-874D-DAF9EC4E7D8D Q27486413-EEDD5E5A-4D3F-4A83-ADD1-295F435A637E Q27487857-4D37045C-4634-48A5-B145-FBA6664B0596 Q27489807-076086E3-9CC5-482C-A682-232711A00C21 Q27490424-0C86596E-5092-4395-962A-BB1149EE9126 Q28066101-E958B301-C00E-4581-8F5A-1C333BA61476 Q28554197-62062FB3-CD34-4DA9-8E80-97C7E9CE5FC3 Q28590801-AAD71B60-933B-4275-A7FD-FECB212646E4 Q33713525-1D34F287-6C83-4144-A918-23EB591640EE Q34016744-AF4474F7-859B-45E1-B31F-4273B914E48E Q34473336-20DE0FFC-D637-47B5-AAA5-C47040387BFE Q34787775-9F26E724-7355-4201-A471-C8C38E2B54AB Q35119681-73D1295A-35D7-43EB-86E2-D86517C094C7 Q35270489-CAE6CF12-EE9F-4F6B-9960-1F05247208B7 Q35289367-35397652-2DD0-444B-AAF8-9DE4F0D51FB4 Q35853760-1A954C7B-50D8-42BA-AD45-E97D68F6E547 Q36432717-BB55DE77-D7A7-4092-8F4A-8DB670C4CBFE Q36883989-FB202A21-BD71-47ED-A8C8-A5390F2EF9DA Q36897347-47FC5DD3-ADFA-4057-A382-87338BB9E8BC Q36972091-0A5F30F5-A971-4A17-AEEF-F16D808F5CDF Q36972120-17F0F09A-0389-4CD9-84B4-CEE641514F1A Q36989997-AA7078CB-9998-4AE4-A1C7-9640704EC458 Q37099661-00C26F8B-6F66-4AE6-9A25-ACE1BE4285D0 Q37165327-865C438D-2236-4064-BE98-50D2233DAF39 Q37190830-DC1A06C2-9831-4521-BEB9-7D2140E7FD9C Q37230918-C29F05E9-097D-4AE4-B0AA-A7DFC21C74E5 Q37347451-351647E0-A48C-4B71-90A1-1D7E5A9C3995 Q37850458-427D6F82-8BAF-4F93-9079-A9CDB5C5F06B Q37909000-FF61BEAD-5F62-42AF-9857-40E9291E1871 Q38010767-865528C0-FCAA-444B-8F25-9F98BC0CF522 Q38186137-BD08075C-DCCA-4116-B999-8E677957D8E2 Q38265619-EFCBCD0F-BAFD-4F99-B3B5-A58838CE359D Q38298812-081432B5-152E-45B4-9F01-1B940A8DA2F2 Q38300633-8257EF9B-4A5B-4C14-8F7C-3D2D62CB8522 Q38898494-F4EF1841-6FB9-4F22-8F9D-A47A53BDE21C Q38974187-1C96B064-BDE5-45AC-9A23-8D0E4570D3B4 Q38974213-1B5A3319-493E-4F20-8103-3A32B2B1B59F

P2860

Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

http://www.wikidata.org/entity/Q34000829

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Vectorization of morpholino ol ...... sence of endosomolytic agents.

@ast

Vectorization of morpholino ol ...... sence of endosomolytic agents.

@en

Vectorization of morpholino oligomers by the

@nl

type

label

Vectorization of morpholino ol ...... sence of endosomolytic agents.

@ast

Vectorization of morpholino ol ...... sence of endosomolytic agents.

@en

Vectorization of morpholino oligomers by the

@nl

prefLabel

Vectorization of morpholino ol ...... sence of endosomolytic agents.

@ast

Vectorization of morpholino ol ...... sence of endosomolytic agents.

@en

Vectorization of morpholino oligomers by the

@nl

P1433

Q34000829-172104CE-22CC-4A4C-A7A5-3583AA16915E

P1476

Q34000829-37A2E1B5-CC1E-4E49-BE43-D75934D41B80

P2093

Q34000829-1665A40E-C742-49FB-BEA9-4A7E92AC3232

Q34000829-168B0444-72AD-4C05-AEC6-D89DCFA6C4B4

Q34000829-35F94B5B-FAE4-4353-B64A-82B427F755FE

Q34000829-79BB68B3-9A04-43E5-8E15-0D7384EC3005

Q34000829-C5F36351-4165-45C3-9B3A-6205C683196C

Q34000829-EA71B711-9B52-4BAF-8A75-55D0C8A9B449

Q34000829-F569393D-2232-4E44-B5D7-075A218FFAAC

P304

Q34000829-283F22A6-F742-4C7B-AC05-D5EFC64B2141

P31

Q34000829-E159BB6B-3FD5-4A1F-BC81-044EC7DADEEA

P356

Q34000829-2A683106-4C82-45BA-8EB2-EBD0AFEABE6A

P407

Q34000829-3D36AC59-1E4B-427B-8873-0357710830C7

P433

Q34000829-E9E9E155-EDB2-4CB5-8EBD-4932BB6D60A1

P478

Q34000829-2834828A-984B-4C73-998D-0AD5B653F608

P50

Q34000829-D7DC5452-E06F-48C2-B299-1C12F38071A3

P577

Q34000829-538F832D-F515-43E2-81DA-DB188FB9047B

P698

Q34000829-BF24D8DE-CFD4-4B21-86E3-B9D2CD023F94

P356

J.JCONREL.2006.09.011

P1433

Journal of Controlled Release

P1476

Vectorization of morpholino ol ...... bsence of endosomolytic agents

@en

P2093

Bernard Lebleu

http://www.w3.org/2001/XMLSchema#string

Derek S Youngblood

http://www.w3.org/2001/XMLSchema#string

Hong M Moulton

http://www.w3.org/2001/XMLSchema#string

Paul Prevot

http://www.w3.org/2001/XMLSchema#string

Philippe Clair

http://www.w3.org/2001/XMLSchema#string

Rebecca P Wu

http://www.w3.org/2001/XMLSchema#string

Saïd Abes

http://www.w3.org/2001/XMLSchema#string

P304

304-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2006.09.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Patrick L Iversen

P577

2006-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17097177

http://www.w3.org/2001/XMLSchema#string